This page provides links to a selection of upcoming calls from the Horizon Europe and other European programmes. These have been selected by the ESE Science Committee as calls that are likely to have relevance to endocrinologists.
Upcoming Cluster 1 Health Calls
Upcoming Cluster 1 Health Calls
- Both calls opened on 25 April 2024 with deadline on 26 November 2024
There are also following CSA and CoFund calls. They are aimed at research funders, policy makers, government departments and are not aimed at researchers.
- HORIZON-HLTH-2024-DISEASE-17-01: Pandemic preparedness and response: Maintaining and enhancing the preparatory work for a co-funded European partnership for pandemic preparedness
- HORIZON-HLTH-2024-DISEASE-12-01: European partnership for pandemic preparedness
- HORIZON-HLTH-2024-DISEASE-09-01: European Partnership: One Health AntiMicrobial Resistance
Mission Cancer
Mission Cancer has launched its new calls for 2024, with a total budget of 119 M€. All calls opening: 18 Apr 2024 with deadlines on 18 Sep 2024
The calls are the following
HORIZON-MISS-2024-CANCER-01-01: Use cases for the UNCAN.eu research data platform
HORIZON-MISS-2024-CANCER-01-04: Support a pragmatic clinical trial programme by cancer charities
MSCA and ERC
MSCA calls
The European Commission has announced new calls under the Marie Skłodowska-Curie Actions (MSCA) in 2024. This year, the MSCA will provide organisations with over €1.25 billionto fund cutting-edge research through excellent doctoral and postdoctoral programmes, collaborative research and innovation projects and research fellowships.
MSCA Postdoctoral Fellowships 2024
Opening date 23 April 2024
Deadline date 11 September 202
Opening date 23 April 2024
Deadline date 26 September 2024
Planned opening date 10 October 2024
Deadline date 05 March 2025
Planned opening date 12 September 2024
Deadline date 14 January 202
Planned opening date 29 May 2024
Deadline date 27 November 2024
European Research Council Calls 2024
| Call | Identifier | Call Opens | Deadline Date |
|---|---|---|---|
| ERC Advanced Grant | ERC-2024-AdG | 29 May 2024 | 29 Aug 2024 |
| ERC Proof of Concept (only for ERC Grant holders) | ERC-2024-PoC | 16 Nov 2023 | I 14 Mar 2024; II 17 Sep 2024 |
For more information, please consult the ERC Workprogramme 2024 (PDF).
The Innovative Health Initiative (IHI)
Innovative Health Initiative (IHI) is a partnership for health research and innovation between the EU (funded through Horizon Europe) and Europe's life science industries. Scientists from academia, diverse industry sectors, SMEs, mid-sized companies, hospitals and patients’ organisations are encouraged to get involved. The IHI holds regular calls for proposals.
The IHI has published its 2024 Work Programme and has launched Call 6 and 7
Call 6 topics:
- Topic 1: Support healthcare system resilience through a focus on persistency in the treatment of chronic diseases
- Topic 2: Development of evidence based practical guidance for sponsors on the use of real-world data / real-world evidence
Call 6 invites two stage applications with first stage deadline on 16 April 2024 and full proposal submission deadline: 10 October 2024.
Call 7 topics
- Topic 1:Improving clinical management of heart disease from early detection to treatment
- Topic 2: User-centric technologies and optimised hospital workflows for a sustainable healthcare workforce
- Topic 3: Clinical validation of biomarkers for diagnosis, monitoring disease progression and treatment response
Full proposal submission deadline: 22 May 2024
The IHI organised a series of info and pitching sessions on Call 6 and Call 7 , and there is also an online brokerage platform
Find out more
- All topic texts, call documentation (including a comprehensiveguide for applicants), details of how to apply and guidance on how to find project partners can be found on the IHI website.
Global Health European and Developing Countries Clinical Trials Partnership (GH EDCTP3)
The GH EDCTP3 partnership funds collaborative clinical research on medicinal products and supports the capacity for sub-Saharan African countries to conduct high-quality clinical studies
GH EDCTP3 recently published their Work Programme for 2024.. There are seven 2024 call topics worth €140m, with a first stage deadline of 4 April 2024, second stage 12 September 2024
The calls are following:
- Research on existing Malaria vaccines and development of new promising candidates-
- New tools, technologies and approaches for vector control in sub-Saharan Africa
- Accelerating development and integration of therapeutics against Neglected Tropical Diseases (NTDs) in sub-Saharan Africa
- Global Health EDCTP3 JU training fellowship with return phase
- Tackling Antimicrobial Resistance (AMR) through R&D in novel and existing antimicrobials
- Innovative digital health solutions for sub-Saharan Africa
- Developing novel, innovative HIV therapeutics for reducing the disease burden of HIV in sub-Saharan Africa
For more information please see https://www.globalhealth-edctp3.eu/funding/calls-proposals and presentation from call information day https://www.globalhealth-edctp3.eu/sites/default/files/2024-02/Info%20day%202024%20presentation.pdf
European Partnership for Personalised Medicine (EP PerMed) Launched including First Call
The European Partnership for Personalised Medicine has been launched and follows on from the ICPerMed project. EP PerMed aims to improve future healthcare for all citizens through personalised therapy, diagnosis and prevention. It has a total budget of around €375 million provided by the EU (from Horizon Europe) and more than 50 partners (that are mainly funding organisations from Europe and beyond). EP PerMed will not only significantly support the transnational development of personalised medicine approaches over the next ten years, but also their successful translation into clinical practice.
Because EP PeMed is a co-funded partnership, it does not follow the normal Horizon Europe eligibility and funding rules - potential applicants should check on a call by call basis to see which countries and types of organisation are eligible for funding.
EP PerMed has announced its first call for proposals "Identification or Validation of Targets for Personalised Medicine Approaches (PMTargets)" with deadline for pre-proposal submission on 5 March 2024 and deadline for full-proposal submission on 20 June 2024.
The European Partnership on transforming health and care systems (THCS) - Pre-Announcement of The Second Joint Transnational Call
THCS is a Cofund action under the Horizon Europe Programme designed to support coordinated national and regional research and innovation programmes along with capacity building, networking, dissemination and other key activities to support health and care systems transformation.
Second Joint Translational call aims to support the implementation of innovative person-centred health and care models addressing prevention strategies, with the key help of existing IT and digital technologies and services.
CALL TIMELINE
|
February 20, 2024 |
Publication of the call |
|
March, 2024 |
JTC2024 Information day for applicants |
|
April 16, 2024 |
Deadline for submission of Intent to Apply |
|
May 14, 2024 |
Deadline for submission of proposals |
For more information please refer to relevant THCS webpage
European Joint Programme on Rare Diseases
HORIZON-CL4-2024-RESILIENCE-01-36 Advanced biomaterials for the Health Care (IA) - two stage call - I deadline 07 February 2024, II deadline 24 September 2024